NETRI and Axol Bioscience announce a strategic partnership to launch organs-on-chip kits including both NETRI’s neuro-organs-on-chip devices and Axol’s human induced pluripotent stem cells (hiPSC) with reagents to boost pharmaceutical industry access to organs on chip.
From January 9 to 11, 2023, meet our CEO & Co-Founder Thibault Honegger at Business France North America’s French Healthcare Corner, located at Café Bastille in San Francisco.
After a year of innovation in 2022, we look forward to presenting all our new projects in 2023
Tessara and NETRI will collaborate to combine the RealBrain® neural micro-tissues with the NeoBentoTM high-throughput microfluidic platform. The combination of the physiological relevance of fully functional 3D neural micro-tissues with the high-throughput microfluidics platform is expected to deliver a family of next generation drug discovery tools.
Après avoir remporté le prix Coup de cœur du jury en 2019, nous sommes fiers d’être cette année encore parmi les finalistes dans la catégorie santé et industrie de la 17ème édition des Trophées Bref Eco.
We are excited to announce that we are launching our first “Capabilities lunch” LikedIn live webinars! Discover the program.
ORGANS-ON-CHIP KITS
Quickly and easily adopt organs-on-chip
into users’ research
